Kaveri Pohlman's Stock Ratings

BTIG Analyst

Kaveri Pohlman is an analyst at BTIG. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/23/2025

Overall Average Return

-32.5%

Smart Score

25.9%

Overall Average Return Percentile

6th

Number of Ratings

28
Buy NowGet Alert
08/01/2024MGNXBuy Now
Macrogenics
$1.35
Kaveri Pohlman25%
DowngradeBuy → NeutralGet Alert
06/27/2024GMABBuy Now
Genmab
$21.45119.11%
Kaveri Pohlman25%
$46 → $47MaintainsBuyGet Alert
05/24/2024MGNXBuy Now
Macrogenics
$1.35566.67%
Kaveri Pohlman25%
$24 → $9MaintainsBuyGet Alert
04/17/2024CGEMBuy Now
Cullinan Oncology
$7.67291.13%
Kaveri Pohlman25%
$20 → $30MaintainsBuyGet Alert
04/16/2024XNCRBuy Now
Xencor
$8.54344.96%
Kaveri Pohlman25%
$56 → $38MaintainsBuyGet Alert
03/26/2024NUVBBuy Now
Nuvation Bio
$1.96155.09%
Kaveri Pohlman25%
→ $5UpgradeNeutral → BuyGet Alert
03/21/2024JANXBuy Now
Janux Therapeutics
$23.60162.71%
Kaveri Pohlman25%
→ $62Initiates → BuyGet Alert
03/04/2024MGNXBuy Now
Macrogenics
$1.351677.78%
Kaveri Pohlman25%
$12 → $24MaintainsBuyGet Alert
02/09/2024PYXSBuy Now
Pyxis Oncology
$1.17583.76%
Kaveri Pohlman25%
→ $8Initiates → BuyGet Alert
12/19/2023EXELBuy Now
Exelixis
$40.37-33.12%
Kaveri Pohlman25%
→ $27Initiates → BuyGet Alert
10/13/2023GMABBuy Now
Genmab
$21.45114.45%
Kaveri Pohlman25%
$44 → $46MaintainsBuyGet Alert
09/12/2023AMAMBuy Now
Ambrx Biopharma
Kaveri Pohlman25%
→ $26Initiates → BuyGet Alert
08/24/2023GMABBuy Now
Genmab
$21.45105.13%
Kaveri Pohlman25%
→ $44Initiates → BuyGet Alert
08/23/2023RCUSBuy Now
Arcus Biosciences
$8.62712.06%
Kaveri Pohlman25%
→ $70ReiteratesBuy → BuyGet Alert
03/21/2023MGNXBuy Now
Macrogenics
$1.35788.89%
Kaveri Pohlman25%
$6 → $12MaintainsBuyGet Alert
11/21/2022CGEMBuy Now
Cullinan Oncology
$7.67160.76%
Kaveri Pohlman25%
→ $20Initiates → BuyGet Alert
11/14/2022ONCSBuy Now
OncoSec Medical
Kaveri Pohlman25%
DowngradeBuy → NeutralGet Alert
08/31/2022STTKBuy Now
Shattuck Labs
$0.961154.05%
Kaveri Pohlman25%
→ $12Initiates → BuyGet Alert
08/02/2022NUVBBuy Now
Nuvation Bio
$1.96
Kaveri Pohlman25%
DowngradeBuy → NeutralGet Alert
07/07/2022CTMXBuy Now
CytomX Therapeutics
$2.34241.88%
Kaveri Pohlman25%
$16 → $8MaintainsBuyGet Alert
06/01/2022NEXIBuy Now
NexImmune
$0.004999900%
Kaveri Pohlman25%
→ $5Initiates → BuyGet Alert
04/20/2022CMPIBuy Now
Checkmate Pharmaceuticals
Kaveri Pohlman25%
DowngradeBuy → NeutralGet Alert
03/30/2022CMPIBuy Now
Checkmate Pharmaceuticals
Kaveri Pohlman25%
$29 → $9MaintainsBuyGet Alert
03/16/2022ONCSBuy Now
OncoSec Medical
Kaveri Pohlman25%
$10 → $5MaintainsBuyGet Alert
02/24/2022ONCTBuy Now
Oncternal Therapeutics
Kaveri Pohlman25%
→ $5Initiates → BuyGet Alert
02/09/2022SONNBuy Now
Sonnet BioTherapeutics
$1.2066.67%
Kaveri Pohlman25%
$5 → $2MaintainsBuyGet Alert
11/15/2021CTMXBuy Now
CytomX Therapeutics
$2.34583.76%
Kaveri Pohlman25%
→ $16Initiates → BuyGet Alert
09/15/2021SONNBuy Now
Sonnet BioTherapeutics
$1.20316.67%
Kaveri Pohlman25%
→ $5Initiates → BuyGet Alert